nodes	percent_of_prediction	percent_of_DWPC	metapath
Tizanidine—NISCH—Paclitaxel—Docetaxel—stomach cancer	0.0182	1	CbGdCrCtD
Tizanidine—Shock—Capecitabine—stomach cancer	0.000484	0.000591	CcSEcCtD
Tizanidine—Rhinitis—Epirubicin—stomach cancer	0.000484	0.000591	CcSEcCtD
Tizanidine—Conjunctivitis—Doxorubicin—stomach cancer	0.000484	0.00059	CcSEcCtD
Tizanidine—Nervous system disorder—Capecitabine—stomach cancer	0.000483	0.000589	CcSEcCtD
Tizanidine—Haemorrhage—Epirubicin—stomach cancer	0.000483	0.000589	CcSEcCtD
Tizanidine—Hepatitis—Epirubicin—stomach cancer	0.000483	0.000589	CcSEcCtD
Tizanidine—Diarrhoea—Fluorouracil—stomach cancer	0.000482	0.000588	CcSEcCtD
Tizanidine—Thrombocytopenia—Capecitabine—stomach cancer	0.000482	0.000588	CcSEcCtD
Tizanidine—Tinnitus—Methotrexate—stomach cancer	0.000481	0.000587	CcSEcCtD
Tizanidine—Tachycardia—Capecitabine—stomach cancer	0.00048	0.000586	CcSEcCtD
Tizanidine—Pharyngitis—Epirubicin—stomach cancer	0.000479	0.000585	CcSEcCtD
Tizanidine—Cardiac disorder—Methotrexate—stomach cancer	0.000479	0.000584	CcSEcCtD
Tizanidine—Skin disorder—Capecitabine—stomach cancer	0.000478	0.000584	CcSEcCtD
Tizanidine—Sweating—Doxorubicin—stomach cancer	0.000477	0.000582	CcSEcCtD
Tizanidine—Urinary tract disorder—Epirubicin—stomach cancer	0.000477	0.000582	CcSEcCtD
Tizanidine—Hyperhidrosis—Capecitabine—stomach cancer	0.000476	0.000581	CcSEcCtD
Tizanidine—Hypotension—Docetaxel—stomach cancer	0.000475	0.00058	CcSEcCtD
Tizanidine—Haematuria—Doxorubicin—stomach cancer	0.000474	0.000579	CcSEcCtD
Tizanidine—Connective tissue disorder—Epirubicin—stomach cancer	0.000474	0.000579	CcSEcCtD
Tizanidine—Urethral disorder—Epirubicin—stomach cancer	0.000473	0.000577	CcSEcCtD
Tizanidine—Hepatobiliary disease—Doxorubicin—stomach cancer	0.000471	0.000574	CcSEcCtD
Tizanidine—Angiopathy—Methotrexate—stomach cancer	0.000468	0.000571	CcSEcCtD
Tizanidine—Vomiting—Irinotecan—stomach cancer	0.000468	0.000571	CcSEcCtD
Tizanidine—Sinusitis—Doxorubicin—stomach cancer	0.000467	0.00057	CcSEcCtD
Tizanidine—Immune system disorder—Methotrexate—stomach cancer	0.000466	0.000569	CcSEcCtD
Tizanidine—Dizziness—Fluorouracil—stomach cancer	0.000466	0.000568	CcSEcCtD
Tizanidine—Mediastinal disorder—Methotrexate—stomach cancer	0.000465	0.000567	CcSEcCtD
Tizanidine—Agranulocytosis—Doxorubicin—stomach cancer	0.000464	0.000567	CcSEcCtD
Tizanidine—Rash—Irinotecan—stomach cancer	0.000464	0.000566	CcSEcCtD
Tizanidine—Dermatitis—Irinotecan—stomach cancer	0.000463	0.000565	CcSEcCtD
Tizanidine—Musculoskeletal discomfort—Docetaxel—stomach cancer	0.000463	0.000565	CcSEcCtD
Tizanidine—Hypotension—Capecitabine—stomach cancer	0.00046	0.000561	CcSEcCtD
Tizanidine—Paraesthesia—Docetaxel—stomach cancer	0.000457	0.000557	CcSEcCtD
Tizanidine—Erythema multiforme—Epirubicin—stomach cancer	0.000456	0.000557	CcSEcCtD
Tizanidine—Alopecia—Methotrexate—stomach cancer	0.000456	0.000556	CcSEcCtD
Tizanidine—Bradycardia—Doxorubicin—stomach cancer	0.000455	0.000555	CcSEcCtD
Tizanidine—Dyspnoea—Docetaxel—stomach cancer	0.000453	0.000553	CcSEcCtD
Tizanidine—Somnolence—Docetaxel—stomach cancer	0.000452	0.000552	CcSEcCtD
Tizanidine—Mental disorder—Methotrexate—stomach cancer	0.000452	0.000551	CcSEcCtD
Tizanidine—Tinnitus—Epirubicin—stomach cancer	0.00045	0.000549	CcSEcCtD
Tizanidine—Haemoglobin—Doxorubicin—stomach cancer	0.000449	0.000548	CcSEcCtD
Tizanidine—Musculoskeletal discomfort—Capecitabine—stomach cancer	0.000449	0.000547	CcSEcCtD
Tizanidine—Cardiac disorder—Epirubicin—stomach cancer	0.000448	0.000547	CcSEcCtD
Tizanidine—Vomiting—Fluorouracil—stomach cancer	0.000448	0.000547	CcSEcCtD
Tizanidine—Rhinitis—Doxorubicin—stomach cancer	0.000448	0.000546	CcSEcCtD
Tizanidine—Dyspepsia—Docetaxel—stomach cancer	0.000448	0.000546	CcSEcCtD
Tizanidine—Haemorrhage—Doxorubicin—stomach cancer	0.000447	0.000545	CcSEcCtD
Tizanidine—Hepatitis—Doxorubicin—stomach cancer	0.000447	0.000545	CcSEcCtD
Tizanidine—Rash—Fluorouracil—stomach cancer	0.000444	0.000542	CcSEcCtD
Tizanidine—Dermatitis—Fluorouracil—stomach cancer	0.000444	0.000542	CcSEcCtD
Tizanidine—Pharyngitis—Doxorubicin—stomach cancer	0.000443	0.000541	CcSEcCtD
Tizanidine—Paraesthesia—Capecitabine—stomach cancer	0.000442	0.000539	CcSEcCtD
Tizanidine—Urinary tract disorder—Doxorubicin—stomach cancer	0.000441	0.000538	CcSEcCtD
Tizanidine—Connective tissue disorder—Doxorubicin—stomach cancer	0.000439	0.000536	CcSEcCtD
Tizanidine—Dyspnoea—Capecitabine—stomach cancer	0.000439	0.000536	CcSEcCtD
Tizanidine—Fatigue—Docetaxel—stomach cancer	0.000438	0.000535	CcSEcCtD
Tizanidine—Angiopathy—Epirubicin—stomach cancer	0.000438	0.000534	CcSEcCtD
Tizanidine—Urethral disorder—Doxorubicin—stomach cancer	0.000438	0.000534	CcSEcCtD
Tizanidine—Nausea—Irinotecan—stomach cancer	0.000437	0.000533	CcSEcCtD
Tizanidine—Immune system disorder—Epirubicin—stomach cancer	0.000436	0.000532	CcSEcCtD
Tizanidine—Mediastinal disorder—Epirubicin—stomach cancer	0.000435	0.000531	CcSEcCtD
Tizanidine—Constipation—Docetaxel—stomach cancer	0.000435	0.000531	CcSEcCtD
Tizanidine—Back pain—Methotrexate—stomach cancer	0.000434	0.00053	CcSEcCtD
Tizanidine—Dyspepsia—Capecitabine—stomach cancer	0.000433	0.000529	CcSEcCtD
Tizanidine—Arrhythmia—Epirubicin—stomach cancer	0.000431	0.000526	CcSEcCtD
Tizanidine—Alopecia—Epirubicin—stomach cancer	0.000427	0.000521	CcSEcCtD
Tizanidine—Fatigue—Capecitabine—stomach cancer	0.000424	0.000518	CcSEcCtD
Tizanidine—Vision blurred—Methotrexate—stomach cancer	0.000423	0.000516	CcSEcCtD
Tizanidine—Mental disorder—Epirubicin—stomach cancer	0.000423	0.000516	CcSEcCtD
Tizanidine—Erythema multiforme—Doxorubicin—stomach cancer	0.000422	0.000515	CcSEcCtD
Tizanidine—Constipation—Capecitabine—stomach cancer	0.000421	0.000514	CcSEcCtD
Tizanidine—Feeling abnormal—Docetaxel—stomach cancer	0.000419	0.000511	CcSEcCtD
Tizanidine—Nausea—Fluorouracil—stomach cancer	0.000418	0.000511	CcSEcCtD
Tizanidine—Ill-defined disorder—Methotrexate—stomach cancer	0.000417	0.000508	CcSEcCtD
Tizanidine—Tinnitus—Doxorubicin—stomach cancer	0.000416	0.000508	CcSEcCtD
Tizanidine—Gastrointestinal pain—Docetaxel—stomach cancer	0.000416	0.000507	CcSEcCtD
Tizanidine—Anaemia—Methotrexate—stomach cancer	0.000415	0.000506	CcSEcCtD
Tizanidine—Cardiac disorder—Doxorubicin—stomach cancer	0.000415	0.000506	CcSEcCtD
Tizanidine—Flatulence—Epirubicin—stomach cancer	0.000414	0.000505	CcSEcCtD
Tizanidine—Tension—Epirubicin—stomach cancer	0.000412	0.000503	CcSEcCtD
Tizanidine—Nervousness—Epirubicin—stomach cancer	0.000408	0.000498	CcSEcCtD
Tizanidine—Back pain—Epirubicin—stomach cancer	0.000406	0.000496	CcSEcCtD
Tizanidine—Feeling abnormal—Capecitabine—stomach cancer	0.000406	0.000495	CcSEcCtD
Tizanidine—Angiopathy—Doxorubicin—stomach cancer	0.000405	0.000495	CcSEcCtD
Tizanidine—Malaise—Methotrexate—stomach cancer	0.000405	0.000494	CcSEcCtD
Tizanidine—Muscle spasms—Epirubicin—stomach cancer	0.000404	0.000493	CcSEcCtD
Tizanidine—Immune system disorder—Doxorubicin—stomach cancer	0.000403	0.000492	CcSEcCtD
Tizanidine—Vertigo—Methotrexate—stomach cancer	0.000403	0.000492	CcSEcCtD
Tizanidine—Gastrointestinal pain—Capecitabine—stomach cancer	0.000403	0.000491	CcSEcCtD
Tizanidine—Mediastinal disorder—Doxorubicin—stomach cancer	0.000403	0.000491	CcSEcCtD
Tizanidine—Body temperature increased—Docetaxel—stomach cancer	0.000402	0.00049	CcSEcCtD
Tizanidine—Abdominal pain—Docetaxel—stomach cancer	0.000402	0.00049	CcSEcCtD
Tizanidine—Leukopenia—Methotrexate—stomach cancer	0.000402	0.00049	CcSEcCtD
Tizanidine—Arrhythmia—Doxorubicin—stomach cancer	0.000399	0.000487	CcSEcCtD
Tizanidine—Vision blurred—Epirubicin—stomach cancer	0.000396	0.000483	CcSEcCtD
Tizanidine—Alopecia—Doxorubicin—stomach cancer	0.000395	0.000482	CcSEcCtD
Tizanidine—Mental disorder—Doxorubicin—stomach cancer	0.000391	0.000478	CcSEcCtD
Tizanidine—Urticaria—Capecitabine—stomach cancer	0.000391	0.000477	CcSEcCtD
Tizanidine—Ill-defined disorder—Epirubicin—stomach cancer	0.00039	0.000476	CcSEcCtD
Tizanidine—Abdominal pain—Capecitabine—stomach cancer	0.000389	0.000475	CcSEcCtD
Tizanidine—Body temperature increased—Capecitabine—stomach cancer	0.000389	0.000475	CcSEcCtD
Tizanidine—Convulsion—Methotrexate—stomach cancer	0.000389	0.000475	CcSEcCtD
Tizanidine—Anaemia—Epirubicin—stomach cancer	0.000388	0.000474	CcSEcCtD
Tizanidine—Agitation—Epirubicin—stomach cancer	0.000386	0.000471	CcSEcCtD
Tizanidine—Flatulence—Doxorubicin—stomach cancer	0.000383	0.000468	CcSEcCtD
Tizanidine—Arthralgia—Methotrexate—stomach cancer	0.000382	0.000467	CcSEcCtD
Tizanidine—Tension—Doxorubicin—stomach cancer	0.000382	0.000466	CcSEcCtD
Tizanidine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	0.00038	0.000463	CcSEcCtD
Tizanidine—Malaise—Epirubicin—stomach cancer	0.000379	0.000462	CcSEcCtD
Tizanidine—Discomfort—Methotrexate—stomach cancer	0.000378	0.000461	CcSEcCtD
Tizanidine—Nervousness—Doxorubicin—stomach cancer	0.000378	0.000461	CcSEcCtD
Tizanidine—Vertigo—Epirubicin—stomach cancer	0.000378	0.000461	CcSEcCtD
Tizanidine—Syncope—Epirubicin—stomach cancer	0.000377	0.00046	CcSEcCtD
Tizanidine—Leukopenia—Epirubicin—stomach cancer	0.000376	0.000459	CcSEcCtD
Tizanidine—Back pain—Doxorubicin—stomach cancer	0.000376	0.000459	CcSEcCtD
Tizanidine—Hypersensitivity—Docetaxel—stomach cancer	0.000375	0.000457	CcSEcCtD
Tizanidine—Muscle spasms—Doxorubicin—stomach cancer	0.000374	0.000456	CcSEcCtD
Tizanidine—Confusional state—Methotrexate—stomach cancer	0.00037	0.000451	CcSEcCtD
Tizanidine—Loss of consciousness—Epirubicin—stomach cancer	0.000369	0.000451	CcSEcCtD
Tizanidine—Anaphylactic shock—Methotrexate—stomach cancer	0.000366	0.000447	CcSEcCtD
Tizanidine—Vision blurred—Doxorubicin—stomach cancer	0.000366	0.000447	CcSEcCtD
Tizanidine—Asthenia—Docetaxel—stomach cancer	0.000365	0.000445	CcSEcCtD
Tizanidine—Convulsion—Epirubicin—stomach cancer	0.000364	0.000444	CcSEcCtD
Tizanidine—Infection—Methotrexate—stomach cancer	0.000364	0.000444	CcSEcCtD
Tizanidine—Hypertension—Epirubicin—stomach cancer	0.000363	0.000443	CcSEcCtD
Tizanidine—Hypersensitivity—Capecitabine—stomach cancer	0.000363	0.000443	CcSEcCtD
Tizanidine—Ill-defined disorder—Doxorubicin—stomach cancer	0.000361	0.00044	CcSEcCtD
Tizanidine—Pruritus—Docetaxel—stomach cancer	0.00036	0.000439	CcSEcCtD
Tizanidine—Nervous system disorder—Methotrexate—stomach cancer	0.000359	0.000439	CcSEcCtD
Tizanidine—Anaemia—Doxorubicin—stomach cancer	0.000359	0.000439	CcSEcCtD
Tizanidine—Thrombocytopenia—Methotrexate—stomach cancer	0.000359	0.000438	CcSEcCtD
Tizanidine—Arthralgia—Epirubicin—stomach cancer	0.000358	0.000437	CcSEcCtD
Tizanidine—Agitation—Doxorubicin—stomach cancer	0.000357	0.000436	CcSEcCtD
Tizanidine—Anxiety—Epirubicin—stomach cancer	0.000357	0.000435	CcSEcCtD
Tizanidine—Skin disorder—Methotrexate—stomach cancer	0.000356	0.000434	CcSEcCtD
Tizanidine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	0.000355	0.000434	CcSEcCtD
Tizanidine—Hyperhidrosis—Methotrexate—stomach cancer	0.000354	0.000432	CcSEcCtD
Tizanidine—Discomfort—Epirubicin—stomach cancer	0.000353	0.000431	CcSEcCtD
Tizanidine—Asthenia—Capecitabine—stomach cancer	0.000353	0.000431	CcSEcCtD
Tizanidine—Malaise—Doxorubicin—stomach cancer	0.000351	0.000428	CcSEcCtD
Tizanidine—Dry mouth—Epirubicin—stomach cancer	0.00035	0.000427	CcSEcCtD
Tizanidine—Vertigo—Doxorubicin—stomach cancer	0.000349	0.000426	CcSEcCtD
Tizanidine—Syncope—Doxorubicin—stomach cancer	0.000349	0.000425	CcSEcCtD
Tizanidine—Pruritus—Capecitabine—stomach cancer	0.000348	0.000425	CcSEcCtD
Tizanidine—Leukopenia—Doxorubicin—stomach cancer	0.000348	0.000425	CcSEcCtD
Tizanidine—Diarrhoea—Docetaxel—stomach cancer	0.000348	0.000425	CcSEcCtD
Tizanidine—Confusional state—Epirubicin—stomach cancer	0.000346	0.000422	CcSEcCtD
Tizanidine—Anaphylactic shock—Epirubicin—stomach cancer	0.000343	0.000419	CcSEcCtD
Tizanidine—Oedema—Epirubicin—stomach cancer	0.000343	0.000419	CcSEcCtD
Tizanidine—Hypotension—Methotrexate—stomach cancer	0.000342	0.000418	CcSEcCtD
Tizanidine—Loss of consciousness—Doxorubicin—stomach cancer	0.000342	0.000417	CcSEcCtD
Tizanidine—Infection—Epirubicin—stomach cancer	0.000341	0.000416	CcSEcCtD
Tizanidine—Shock—Epirubicin—stomach cancer	0.000337	0.000412	CcSEcCtD
Tizanidine—Convulsion—Doxorubicin—stomach cancer	0.000337	0.000411	CcSEcCtD
Tizanidine—Diarrhoea—Capecitabine—stomach cancer	0.000337	0.000411	CcSEcCtD
Tizanidine—Nervous system disorder—Epirubicin—stomach cancer	0.000336	0.00041	CcSEcCtD
Tizanidine—Dizziness—Docetaxel—stomach cancer	0.000336	0.00041	CcSEcCtD
Tizanidine—Thrombocytopenia—Epirubicin—stomach cancer	0.000336	0.00041	CcSEcCtD
Tizanidine—Hypertension—Doxorubicin—stomach cancer	0.000336	0.00041	CcSEcCtD
Tizanidine—Tachycardia—Epirubicin—stomach cancer	0.000335	0.000408	CcSEcCtD
Tizanidine—Musculoskeletal discomfort—Methotrexate—stomach cancer	0.000334	0.000407	CcSEcCtD
Tizanidine—Skin disorder—Epirubicin—stomach cancer	0.000333	0.000407	CcSEcCtD
Tizanidine—Hyperhidrosis—Epirubicin—stomach cancer	0.000332	0.000405	CcSEcCtD
Tizanidine—Arthralgia—Doxorubicin—stomach cancer	0.000331	0.000404	CcSEcCtD
Tizanidine—Anxiety—Doxorubicin—stomach cancer	0.00033	0.000403	CcSEcCtD
Tizanidine—Paraesthesia—Methotrexate—stomach cancer	0.000329	0.000402	CcSEcCtD
Tizanidine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	0.000329	0.000401	CcSEcCtD
Tizanidine—Discomfort—Doxorubicin—stomach cancer	0.000327	0.000399	CcSEcCtD
Tizanidine—Dyspnoea—Methotrexate—stomach cancer	0.000327	0.000399	CcSEcCtD
Tizanidine—Somnolence—Methotrexate—stomach cancer	0.000326	0.000398	CcSEcCtD
Tizanidine—Dizziness—Capecitabine—stomach cancer	0.000326	0.000397	CcSEcCtD
Tizanidine—Dry mouth—Doxorubicin—stomach cancer	0.000324	0.000395	CcSEcCtD
Tizanidine—Vomiting—Docetaxel—stomach cancer	0.000323	0.000395	CcSEcCtD
Tizanidine—Dyspepsia—Methotrexate—stomach cancer	0.000323	0.000394	CcSEcCtD
Tizanidine—Rash—Docetaxel—stomach cancer	0.000321	0.000391	CcSEcCtD
Tizanidine—Hypotension—Epirubicin—stomach cancer	0.00032	0.000391	CcSEcCtD
Tizanidine—Dermatitis—Docetaxel—stomach cancer	0.00032	0.000391	CcSEcCtD
Tizanidine—Confusional state—Doxorubicin—stomach cancer	0.00032	0.00039	CcSEcCtD
Tizanidine—Oedema—Doxorubicin—stomach cancer	0.000317	0.000387	CcSEcCtD
Tizanidine—Anaphylactic shock—Doxorubicin—stomach cancer	0.000317	0.000387	CcSEcCtD
Tizanidine—Fatigue—Methotrexate—stomach cancer	0.000316	0.000386	CcSEcCtD
Tizanidine—Infection—Doxorubicin—stomach cancer	0.000315	0.000385	CcSEcCtD
Tizanidine—Vomiting—Capecitabine—stomach cancer	0.000313	0.000382	CcSEcCtD
Tizanidine—Musculoskeletal discomfort—Epirubicin—stomach cancer	0.000312	0.000381	CcSEcCtD
Tizanidine—Shock—Doxorubicin—stomach cancer	0.000312	0.000381	CcSEcCtD
Tizanidine—Nervous system disorder—Doxorubicin—stomach cancer	0.000311	0.00038	CcSEcCtD
Tizanidine—Thrombocytopenia—Doxorubicin—stomach cancer	0.000311	0.000379	CcSEcCtD
Tizanidine—Rash—Capecitabine—stomach cancer	0.00031	0.000379	CcSEcCtD
Tizanidine—Dermatitis—Capecitabine—stomach cancer	0.00031	0.000378	CcSEcCtD
Tizanidine—Tachycardia—Doxorubicin—stomach cancer	0.00031	0.000378	CcSEcCtD
Tizanidine—Skin disorder—Doxorubicin—stomach cancer	0.000308	0.000376	CcSEcCtD
Tizanidine—Paraesthesia—Epirubicin—stomach cancer	0.000308	0.000376	CcSEcCtD
Tizanidine—Hyperhidrosis—Doxorubicin—stomach cancer	0.000307	0.000374	CcSEcCtD
Tizanidine—Dyspnoea—Epirubicin—stomach cancer	0.000306	0.000373	CcSEcCtD
Tizanidine—Somnolence—Epirubicin—stomach cancer	0.000305	0.000372	CcSEcCtD
Tizanidine—Nausea—Docetaxel—stomach cancer	0.000302	0.000369	CcSEcCtD
Tizanidine—Feeling abnormal—Methotrexate—stomach cancer	0.000302	0.000369	CcSEcCtD
Tizanidine—Dyspepsia—Epirubicin—stomach cancer	0.000302	0.000368	CcSEcCtD
Tizanidine—Gastrointestinal pain—Methotrexate—stomach cancer	0.0003	0.000366	CcSEcCtD
Tizanidine—Hypotension—Doxorubicin—stomach cancer	0.000297	0.000362	CcSEcCtD
Tizanidine—Fatigue—Epirubicin—stomach cancer	0.000296	0.000361	CcSEcCtD
Tizanidine—Constipation—Epirubicin—stomach cancer	0.000293	0.000358	CcSEcCtD
Tizanidine—Nausea—Capecitabine—stomach cancer	0.000292	0.000357	CcSEcCtD
Tizanidine—Urticaria—Methotrexate—stomach cancer	0.000291	0.000355	CcSEcCtD
Tizanidine—Abdominal pain—Methotrexate—stomach cancer	0.00029	0.000354	CcSEcCtD
Tizanidine—Body temperature increased—Methotrexate—stomach cancer	0.00029	0.000354	CcSEcCtD
Tizanidine—Musculoskeletal discomfort—Doxorubicin—stomach cancer	0.000289	0.000353	CcSEcCtD
Tizanidine—Paraesthesia—Doxorubicin—stomach cancer	0.000285	0.000348	CcSEcCtD
Tizanidine—Dyspnoea—Doxorubicin—stomach cancer	0.000283	0.000345	CcSEcCtD
Tizanidine—Feeling abnormal—Epirubicin—stomach cancer	0.000283	0.000345	CcSEcCtD
Tizanidine—Somnolence—Doxorubicin—stomach cancer	0.000282	0.000344	CcSEcCtD
Tizanidine—Gastrointestinal pain—Epirubicin—stomach cancer	0.00028	0.000342	CcSEcCtD
Tizanidine—Dyspepsia—Doxorubicin—stomach cancer	0.000279	0.000341	CcSEcCtD
Tizanidine—Fatigue—Doxorubicin—stomach cancer	0.000274	0.000334	CcSEcCtD
Tizanidine—Urticaria—Epirubicin—stomach cancer	0.000272	0.000332	CcSEcCtD
Tizanidine—Constipation—Doxorubicin—stomach cancer	0.000271	0.000331	CcSEcCtD
Tizanidine—Body temperature increased—Epirubicin—stomach cancer	0.000271	0.000331	CcSEcCtD
Tizanidine—Abdominal pain—Epirubicin—stomach cancer	0.000271	0.000331	CcSEcCtD
Tizanidine—Hypersensitivity—Methotrexate—stomach cancer	0.00027	0.000329	CcSEcCtD
Tizanidine—Asthenia—Methotrexate—stomach cancer	0.000263	0.000321	CcSEcCtD
Tizanidine—Feeling abnormal—Doxorubicin—stomach cancer	0.000262	0.000319	CcSEcCtD
Tizanidine—Gastrointestinal pain—Doxorubicin—stomach cancer	0.000259	0.000317	CcSEcCtD
Tizanidine—Pruritus—Methotrexate—stomach cancer	0.000259	0.000316	CcSEcCtD
Tizanidine—Hypersensitivity—Epirubicin—stomach cancer	0.000253	0.000308	CcSEcCtD
Tizanidine—Urticaria—Doxorubicin—stomach cancer	0.000252	0.000308	CcSEcCtD
Tizanidine—Abdominal pain—Doxorubicin—stomach cancer	0.000251	0.000306	CcSEcCtD
Tizanidine—Body temperature increased—Doxorubicin—stomach cancer	0.000251	0.000306	CcSEcCtD
Tizanidine—Diarrhoea—Methotrexate—stomach cancer	0.000251	0.000306	CcSEcCtD
Tizanidine—Asthenia—Epirubicin—stomach cancer	0.000246	0.0003	CcSEcCtD
Tizanidine—Pruritus—Epirubicin—stomach cancer	0.000243	0.000296	CcSEcCtD
Tizanidine—Dizziness—Methotrexate—stomach cancer	0.000242	0.000296	CcSEcCtD
Tizanidine—Diarrhoea—Epirubicin—stomach cancer	0.000235	0.000286	CcSEcCtD
Tizanidine—Hypersensitivity—Doxorubicin—stomach cancer	0.000234	0.000285	CcSEcCtD
Tizanidine—Vomiting—Methotrexate—stomach cancer	0.000233	0.000284	CcSEcCtD
Tizanidine—Rash—Methotrexate—stomach cancer	0.000231	0.000282	CcSEcCtD
Tizanidine—Dermatitis—Methotrexate—stomach cancer	0.000231	0.000282	CcSEcCtD
Tizanidine—Asthenia—Doxorubicin—stomach cancer	0.000228	0.000278	CcSEcCtD
Tizanidine—Dizziness—Epirubicin—stomach cancer	0.000227	0.000277	CcSEcCtD
Tizanidine—Pruritus—Doxorubicin—stomach cancer	0.000225	0.000274	CcSEcCtD
Tizanidine—Vomiting—Epirubicin—stomach cancer	0.000218	0.000266	CcSEcCtD
Tizanidine—Nausea—Methotrexate—stomach cancer	0.000218	0.000266	CcSEcCtD
Tizanidine—Diarrhoea—Doxorubicin—stomach cancer	0.000217	0.000265	CcSEcCtD
Tizanidine—Rash—Epirubicin—stomach cancer	0.000216	0.000264	CcSEcCtD
Tizanidine—Dermatitis—Epirubicin—stomach cancer	0.000216	0.000264	CcSEcCtD
Tizanidine—Dizziness—Doxorubicin—stomach cancer	0.00021	0.000256	CcSEcCtD
Tizanidine—Nausea—Epirubicin—stomach cancer	0.000204	0.000249	CcSEcCtD
Tizanidine—Vomiting—Doxorubicin—stomach cancer	0.000202	0.000246	CcSEcCtD
Tizanidine—Rash—Doxorubicin—stomach cancer	0.0002	0.000244	CcSEcCtD
Tizanidine—Dermatitis—Doxorubicin—stomach cancer	0.0002	0.000244	CcSEcCtD
Tizanidine—Nausea—Doxorubicin—stomach cancer	0.000188	0.00023	CcSEcCtD
Tizanidine—CYP1A2—Metabolism—ALDH7A1—stomach cancer	5.66e-05	0.000349	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—RPS6—stomach cancer	5.64e-05	0.000348	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—ENO1—stomach cancer	5.64e-05	0.000348	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—PRKCB—stomach cancer	5.55e-05	0.000342	CbGpPWpGaD
Tizanidine—ADRA2B—Hemostasis—VEGFA—stomach cancer	5.54e-05	0.000341	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—IL6ST—stomach cancer	5.53e-05	0.000341	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—ADRB1—stomach cancer	5.52e-05	0.00034	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—UMPS—stomach cancer	5.42e-05	0.000334	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—RPS6—stomach cancer	5.27e-05	0.000325	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—PPP2R1A—stomach cancer	5.24e-05	0.000323	CbGpPWpGaD
Tizanidine—ADRA2B—Hemostasis—MAPK3—stomach cancer	5.24e-05	0.000323	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—PRKCB—stomach cancer	5.19e-05	0.00032	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—HBEGF—stomach cancer	5.19e-05	0.000319	CbGpPWpGaD
Tizanidine—ADRA2C—Hemostasis—VEGFA—stomach cancer	5.17e-05	0.000319	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—IL6ST—stomach cancer	5.17e-05	0.000318	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—GSTP1—stomach cancer	5.14e-05	0.000317	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—HMOX1—stomach cancer	5.07e-05	0.000312	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—PDHA1—stomach cancer	5.04e-05	0.000311	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—ECHS1—stomach cancer	5.04e-05	0.000311	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—CD44—stomach cancer	5.01e-05	0.000308	CbGpPWpGaD
Tizanidine—ADRA2B—Hemostasis—MAPK1—stomach cancer	4.99e-05	0.000307	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—AGTR2—stomach cancer	4.98e-05	0.000307	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—HSPB1—stomach cancer	4.98e-05	0.000307	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—IL6R—stomach cancer	4.93e-05	0.000304	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—F2R—stomach cancer	4.92e-05	0.000303	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—BMP2—stomach cancer	4.92e-05	0.000303	CbGpPWpGaD
Tizanidine—ADRA2B—GPCR downstream signaling—RHOA—stomach cancer	4.91e-05	0.000302	CbGpPWpGaD
Tizanidine—ADRA2C—Hemostasis—MAPK3—stomach cancer	4.89e-05	0.000301	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—HBEGF—stomach cancer	4.84e-05	0.000298	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—AKR1C3—stomach cancer	4.84e-05	0.000298	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—HTR1A—stomach cancer	4.79e-05	0.000295	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—ADRB2—stomach cancer	4.79e-05	0.000295	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—TYMS—stomach cancer	4.78e-05	0.000294	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—TYMP—stomach cancer	4.74e-05	0.000292	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—FADS1—stomach cancer	4.74e-05	0.000292	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—GSTM1—stomach cancer	4.72e-05	0.000291	CbGpPWpGaD
Tizanidine—ADRA2B—Hemostasis—KRAS—stomach cancer	4.71e-05	0.00029	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—PPP2R1A—stomach cancer	4.69e-05	0.000289	CbGpPWpGaD
Tizanidine—ADRA2C—Hemostasis—MAPK1—stomach cancer	4.66e-05	0.000287	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR downstream signaling—PRKCB—stomach cancer	4.64e-05	0.000286	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—ANXA1—stomach cancer	4.63e-05	0.000285	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—IL6R—stomach cancer	4.61e-05	0.000284	CbGpPWpGaD
Tizanidine—ADRA2C—GPCR downstream signaling—RHOA—stomach cancer	4.59e-05	0.000282	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—ADRB1—stomach cancer	4.48e-05	0.000276	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—ADRB2—stomach cancer	4.47e-05	0.000275	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—RHOA—stomach cancer	4.46e-05	0.000275	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—ERCC2—stomach cancer	4.44e-05	0.000274	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—SREBF2—stomach cancer	4.44e-05	0.000274	CbGpPWpGaD
Tizanidine—ADRA2C—Hemostasis—KRAS—stomach cancer	4.4e-05	0.000271	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—RORA—stomach cancer	4.39e-05	0.00027	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—PPP2R1A—stomach cancer	4.38e-05	0.00027	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—SMAD4—stomach cancer	4.36e-05	0.000268	CbGpPWpGaD
Tizanidine—ADRA2B—Hemostasis—PIK3CA—stomach cancer	4.33e-05	0.000266	CbGpPWpGaD
Tizanidine—ADRA2B—GPCR downstream signaling—CXCL8—stomach cancer	4.31e-05	0.000265	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—RPS6—stomach cancer	4.28e-05	0.000264	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—PPP2R1A—stomach cancer	4.26e-05	0.000262	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—PRKCB—stomach cancer	4.21e-05	0.00026	CbGpPWpGaD
Tizanidine—ADRA2A—Hemostasis—VEGFA—stomach cancer	4.2e-05	0.000259	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—IL6ST—stomach cancer	4.2e-05	0.000259	CbGpPWpGaD
Tizanidine—ADRA2B—Hemostasis—TP53—stomach cancer	4.18e-05	0.000258	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—GSTP1—stomach cancer	4.17e-05	0.000257	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—MTHFR—stomach cancer	4.17e-05	0.000257	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—RHOA—stomach cancer	4.16e-05	0.000257	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—FYN—stomach cancer	4.14e-05	0.000255	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—HMOX1—stomach cancer	4.12e-05	0.000254	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—ALDOB—stomach cancer	4.11e-05	0.000253	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—SMAD4—stomach cancer	4.07e-05	0.000251	CbGpPWpGaD
Tizanidine—ADRA2C—Hemostasis—PIK3CA—stomach cancer	4.04e-05	0.000249	CbGpPWpGaD
Tizanidine—ADRA2C—GPCR downstream signaling—CXCL8—stomach cancer	4.03e-05	0.000248	CbGpPWpGaD
Tizanidine—ADRA2B—Hemostasis—HRAS—stomach cancer	4e-05	0.000247	CbGpPWpGaD
Tizanidine—ADRA2A—Hemostasis—MAPK3—stomach cancer	3.98e-05	0.000245	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—HBEGF—stomach cancer	3.94e-05	0.000242	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—CXCL8—stomach cancer	3.91e-05	0.000241	CbGpPWpGaD
Tizanidine—ADRA2C—Hemostasis—TP53—stomach cancer	3.91e-05	0.000241	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—FGFR2—stomach cancer	3.88e-05	0.000239	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—TYMS—stomach cancer	3.88e-05	0.000239	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	3.88e-05	0.000239	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	3.87e-05	0.000238	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—FYN—stomach cancer	3.86e-05	0.000238	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—CAV1—stomach cancer	3.85e-05	0.000237	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—APOA1—stomach cancer	3.84e-05	0.000237	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—GSTM1—stomach cancer	3.84e-05	0.000236	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—ALOX5—stomach cancer	3.82e-05	0.000235	CbGpPWpGaD
Tizanidine—ADRA2A—Hemostasis—MAPK1—stomach cancer	3.78e-05	0.000233	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—DPYD—stomach cancer	3.76e-05	0.000232	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—IL6R—stomach cancer	3.74e-05	0.000231	CbGpPWpGaD
Tizanidine—ADRA2C—Hemostasis—HRAS—stomach cancer	3.74e-05	0.00023	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR downstream signaling—RHOA—stomach cancer	3.72e-05	0.000229	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—CXCL8—stomach cancer	3.66e-05	0.000225	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—ADRB2—stomach cancer	3.63e-05	0.000224	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—FGFR2—stomach cancer	3.63e-05	0.000223	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—ERCC2—stomach cancer	3.61e-05	0.000222	CbGpPWpGaD
Tizanidine—ADRA2A—Hemostasis—KRAS—stomach cancer	3.57e-05	0.00022	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—PPP2R1A—stomach cancer	3.56e-05	0.000219	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—IRS2—stomach cancer	3.55e-05	0.000219	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—CAV1—stomach cancer	3.45e-05	0.000212	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—APOA1—stomach cancer	3.44e-05	0.000212	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	3.41e-05	0.00021	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—MTHFR—stomach cancer	3.39e-05	0.000209	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—PPARG—stomach cancer	3.38e-05	0.000209	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—RHOA—stomach cancer	3.38e-05	0.000208	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—GSTT1—stomach cancer	3.32e-05	0.000205	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—IRS2—stomach cancer	3.32e-05	0.000205	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—SMAD4—stomach cancer	3.3e-05	0.000204	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—CYP2A6—stomach cancer	3.29e-05	0.000202	CbGpPWpGaD
Tizanidine—ADRA2A—Hemostasis—PIK3CA—stomach cancer	3.28e-05	0.000202	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—PRKCB—stomach cancer	3.28e-05	0.000202	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR downstream signaling—CXCL8—stomach cancer	3.27e-05	0.000201	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—IL6ST—stomach cancer	3.27e-05	0.000201	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—CAV1—stomach cancer	3.22e-05	0.000198	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—APOA1—stomach cancer	3.21e-05	0.000198	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—AKR1C3—stomach cancer	3.2e-05	0.000197	CbGpPWpGaD
Tizanidine—ADRA2A—Hemostasis—TP53—stomach cancer	3.18e-05	0.000196	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—APC—stomach cancer	3.14e-05	0.000193	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—FYN—stomach cancer	3.14e-05	0.000193	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—CAV1—stomach cancer	3.13e-05	0.000193	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—APOA1—stomach cancer	3.12e-05	0.000192	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—ENO1—stomach cancer	3.12e-05	0.000192	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—PRKCB—stomach cancer	3.06e-05	0.000189	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—stomach cancer	3.06e-05	0.000189	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—IL6ST—stomach cancer	3.05e-05	0.000188	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—ALB—stomach cancer	3.04e-05	0.000187	CbGpPWpGaD
Tizanidine—ADRA2A—Hemostasis—HRAS—stomach cancer	3.04e-05	0.000187	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—MAPK3—stomach cancer	3.01e-05	0.000185	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—CXCL8—stomach cancer	2.97e-05	0.000183	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—FGFR2—stomach cancer	2.95e-05	0.000181	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—APC—stomach cancer	2.93e-05	0.000181	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—IL6R—stomach cancer	2.92e-05	0.00018	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—NOS3—stomach cancer	2.91e-05	0.000179	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—MAPK1—stomach cancer	2.86e-05	0.000176	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—EGFR—stomach cancer	2.86e-05	0.000176	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—MAPK3—stomach cancer	2.81e-05	0.000173	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—CD44—stomach cancer	2.76e-05	0.00017	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—PPARG—stomach cancer	2.75e-05	0.000169	CbGpPWpGaD
Tizanidine—ADRA2B—GPCR downstream signaling—PIK3CA—stomach cancer	2.73e-05	0.000168	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—SERPINE1—stomach cancer	2.73e-05	0.000168	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—IL6R—stomach cancer	2.72e-05	0.000168	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—KRAS—stomach cancer	2.7e-05	0.000166	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—IRS2—stomach cancer	2.7e-05	0.000166	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	2.68e-05	0.000165	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—MAPK1—stomach cancer	2.67e-05	0.000165	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—EGFR—stomach cancer	2.67e-05	0.000165	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—PTGS2—stomach cancer	2.66e-05	0.000164	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—RHOA—stomach cancer	2.63e-05	0.000162	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—CAV1—stomach cancer	2.62e-05	0.000161	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—APOA1—stomach cancer	2.61e-05	0.000161	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—NOS3—stomach cancer	2.61e-05	0.000161	CbGpPWpGaD
Tizanidine—ADRA2C—GPCR downstream signaling—PIK3CA—stomach cancer	2.55e-05	0.000157	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—SERPINE1—stomach cancer	2.55e-05	0.000157	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—KRAS—stomach cancer	2.52e-05	0.000155	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—PRKCB—stomach cancer	2.49e-05	0.000153	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—PIK3CA—stomach cancer	2.48e-05	0.000153	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—IL6ST—stomach cancer	2.48e-05	0.000153	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—ALB—stomach cancer	2.47e-05	0.000152	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—RHOA—stomach cancer	2.46e-05	0.000152	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—ERBB2—stomach cancer	2.44e-05	0.00015	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—NOS3—stomach cancer	2.43e-05	0.00015	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—APC—stomach cancer	2.38e-05	0.000147	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—NOS3—stomach cancer	2.36e-05	0.000146	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—PPP2R1A—stomach cancer	2.35e-05	0.000145	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—PIK3CA—stomach cancer	2.32e-05	0.000143	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—CXCL8—stomach cancer	2.31e-05	0.000142	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—GSTP1—stomach cancer	2.3e-05	0.000142	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—HRAS—stomach cancer	2.3e-05	0.000141	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—MAPK3—stomach cancer	2.28e-05	0.000141	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—ERBB2—stomach cancer	2.28e-05	0.00014	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—HMOX1—stomach cancer	2.27e-05	0.00014	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—CDKN1B—stomach cancer	2.26e-05	0.000139	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—IL6R—stomach cancer	2.21e-05	0.000136	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—IL6—stomach cancer	2.2e-05	0.000135	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—MAPK1—stomach cancer	2.17e-05	0.000134	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—EGFR—stomach cancer	2.17e-05	0.000134	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—PTGS2—stomach cancer	2.16e-05	0.000133	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—CXCL8—stomach cancer	2.16e-05	0.000133	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—CCND1—stomach cancer	2.15e-05	0.000133	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—JUN—stomach cancer	2.15e-05	0.000132	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—HRAS—stomach cancer	2.15e-05	0.000132	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—TYMS—stomach cancer	2.14e-05	0.000132	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—GSTM1—stomach cancer	2.12e-05	0.00013	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—CDKN1B—stomach cancer	2.11e-05	0.00013	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—MMP9—stomach cancer	2.09e-05	0.000129	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—CDKN1A—stomach cancer	2.08e-05	0.000128	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR downstream signaling—PIK3CA—stomach cancer	2.07e-05	0.000128	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—SERPINE1—stomach cancer	2.07e-05	0.000128	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—IL6—stomach cancer	2.05e-05	0.000126	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—KRAS—stomach cancer	2.05e-05	0.000126	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—MAPK8—stomach cancer	2.03e-05	0.000125	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—CCND1—stomach cancer	2.01e-05	0.000124	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—JUN—stomach cancer	2.01e-05	0.000124	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—RHOA—stomach cancer	2e-05	0.000123	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—ERCC2—stomach cancer	1.99e-05	0.000123	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—NOS3—stomach cancer	1.98e-05	0.000122	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—MMP9—stomach cancer	1.95e-05	0.00012	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—CDKN1A—stomach cancer	1.95e-05	0.00012	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—MAPK8—stomach cancer	1.9e-05	0.000117	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—PIK3CA—stomach cancer	1.88e-05	0.000116	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—VEGFA—stomach cancer	1.88e-05	0.000116	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—MTHFR—stomach cancer	1.87e-05	0.000115	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—STAT3—stomach cancer	1.86e-05	0.000115	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—ERBB2—stomach cancer	1.85e-05	0.000114	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—MAPK3—stomach cancer	1.78e-05	0.000109	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—CXCL8—stomach cancer	1.75e-05	0.000108	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—VEGFA—stomach cancer	1.75e-05	0.000108	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—HRAS—stomach cancer	1.74e-05	0.000107	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—STAT3—stomach cancer	1.74e-05	0.000107	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—MYC—stomach cancer	1.73e-05	0.000106	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—CAV1—stomach cancer	1.73e-05	0.000106	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—APOA1—stomach cancer	1.72e-05	0.000106	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—CDKN1B—stomach cancer	1.71e-05	0.000106	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—MAPK1—stomach cancer	1.69e-05	0.000104	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—EGFR—stomach cancer	1.69e-05	0.000104	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—IL6—stomach cancer	1.67e-05	0.000103	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—MAPK3—stomach cancer	1.66e-05	0.000102	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	1.65e-05	0.000102	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—PIK3CA—stomach cancer	1.64e-05	0.000101	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—CCND1—stomach cancer	1.63e-05	0.000101	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—JUN—stomach cancer	1.63e-05	0.0001	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—MYC—stomach cancer	1.61e-05	9.94e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—KRAS—stomach cancer	1.6e-05	9.83e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—MMP9—stomach cancer	1.59e-05	9.77e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—CDKN1A—stomach cancer	1.58e-05	9.74e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—MAPK1—stomach cancer	1.58e-05	9.72e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—EGFR—stomach cancer	1.58e-05	9.72e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—MAPK8—stomach cancer	1.54e-05	9.5e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—PPARG—stomach cancer	1.52e-05	9.35e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—KRAS—stomach cancer	1.49e-05	9.18e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—PIK3CA—stomach cancer	1.47e-05	9.03e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—VEGFA—stomach cancer	1.42e-05	8.78e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—TP53—stomach cancer	1.42e-05	8.74e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—STAT3—stomach cancer	1.41e-05	8.69e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—PIK3CA—stomach cancer	1.37e-05	8.44e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—ALB—stomach cancer	1.36e-05	8.41e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—HRAS—stomach cancer	1.36e-05	8.36e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—MAPK3—stomach cancer	1.35e-05	8.3e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—PIK3CA—stomach cancer	1.33e-05	8.2e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—TP53—stomach cancer	1.33e-05	8.16e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—MYC—stomach cancer	1.31e-05	8.07e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—NOS3—stomach cancer	1.31e-05	8.04e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—IL6—stomach cancer	1.3e-05	8e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—MAPK1—stomach cancer	1.28e-05	7.9e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—EGFR—stomach cancer	1.28e-05	7.9e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—HRAS—stomach cancer	1.27e-05	7.81e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—IL6—stomach cancer	1.21e-05	7.47e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—KRAS—stomach cancer	1.21e-05	7.46e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—PTGS2—stomach cancer	1.19e-05	7.35e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—PIK3CA—stomach cancer	1.11e-05	6.85e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—TP53—stomach cancer	1.08e-05	6.63e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—HRAS—stomach cancer	1.03e-05	6.34e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—IL6—stomach cancer	9.85e-06	6.07e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—PIK3CA—stomach cancer	7.35e-06	4.52e-05	CbGpPWpGaD
